Series on Knowing What You Don’t Know: The Hidden Variable in Project Success
Part 3: From Siloed Insight to Shared Intelligence — Making Knowledge Actionable
The biggest irony in pharma? The data often exists. The failure lies not in absence, but in access and alignment. Different teams—clinical, regulatory, commercial—may hold fragments of the full picture but fail to assemble them into a coherent view. A missed safety signal, an overlooked regulatory precedent, or an outdated manufacturing spec can derail even the most promising asset.
What’s needed is a knowledge unlocking strategy—a deliberate process to connect insight across roles and domains. This includes:
- Facilitated cross-functional workshops to surface hidden knowledge.
- Reframing knowledge-sharing as risk mitigation, not compliance.
- Incorporating metrics that reward curiosity, not just delivery.
Phetairos advocates for external facilitation precisely because internal hierarchies can suppress dissent. An outsider can ask the questions no one else dares.
Takeaway: Projects fail not because information was absent—but because it was ignored, mislabelled, or never asked for. Unlocking knowledge isn’t an optional extra; it’s the backbone of resilient project planning.
By Mike Florence, Volker Möckel and Stephen Bingham